This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2017-2026.
Company Filing History:
Years Active: 2017-2026
Title: Rosanna Leuzzi: Innovator in Vaccine Development
Introduction
Rosanna Leuzzi is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of vaccine development, particularly in relation to Clostridium difficile. With a total of 3 patents, her work is crucial in advancing medical science and improving public health.
Latest Patents
Leuzzi's latest patents include innovative approaches to combat Clostridium difficile infections. The first patent focuses on Clostridium difficile polypeptides as a vaccine. This invention provides methods, proteins, nucleic acids, and antibodies for preventing or treating infections in mammals. The second patent relates to a Clostridium difficile toxin-based vaccine. It involves recombinant fragments of TcdA and TcdB, which may be used in the development of vaccines against associated diseases. More specifically, it pertains to combinations comprising a ToxB-GT antigen and a TcdA antigen or a ToxA-GT antigen and a TcdB antigen.
Career Highlights
Rosanna Leuzzi is currently associated with GlaxoSmithKline Biologicals SA, where she continues her research and development efforts. Her work has been instrumental in creating effective solutions for serious health issues.
Collaborations
Leuzzi collaborates with talented professionals in her field, including Mariagrazia Pizza and Maria Scarselli. These partnerships enhance her research and contribute to the success of her projects.
Conclusion
Rosanna Leuzzi is a dedicated inventor whose work in vaccine development is making a significant impact on healthcare. Her innovative patents and collaborations reflect her commitment to advancing medical science.